186 related articles for article (PubMed ID: 24374500)
1. Approved but non-funded vaccines: accessing individual protection.
Scheifele DW; Ward BJ; Halperin SA; McNeil SA; Crowcroft NS; Bjornson G
Vaccine; 2014 Feb; 32(7):766-70. PubMed ID: 24374500
[TBL] [Abstract][Full Text] [Related]
2. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
[TBL] [Abstract][Full Text] [Related]
3. Global support for new vaccine implementation in middle-income countries.
Kaddar M; Schmitt S; Makinen M; Milstien J
Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
[TBL] [Abstract][Full Text] [Related]
4. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
5. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
[TBL] [Abstract][Full Text] [Related]
6. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
7. Clinicians' opinions on new vaccination programs implementation.
Dubé E; Gilca V; Sauvageau C; Bettinger JA; Boucher FD; McNeil S; Gemmill I; Lavoie F; Ouakki M; Boulianne N
Vaccine; 2012 Jun; 30(31):4632-7. PubMed ID: 22580354
[TBL] [Abstract][Full Text] [Related]
8. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges.
Gordon WS; Jones A; Wecker J
Health Policy Plan; 2012 May; 27 Suppl 2():ii17-26. PubMed ID: 22513729
[TBL] [Abstract][Full Text] [Related]
9. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
10. Vaccine development and deployment: opportunities and challenges in India.
Gupta SS; Nair GB; Arora NK; Ganguly NK
Vaccine; 2013 Apr; 31 Suppl 2():B43-53. PubMed ID: 23598492
[TBL] [Abstract][Full Text] [Related]
11. Health insurance and preventive care sources of children at public immunization clinics.
Lieu TA; Smith MD; Newacheck PW; Langthorn D; Venkatesh P; Herradora R
Pediatrics; 1994 Mar; 93(3):373-8. PubMed ID: 8115194
[TBL] [Abstract][Full Text] [Related]
12. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience.
De Wals P
Expert Rev Vaccines; 2011 Jan; 10(1):55-62. PubMed ID: 21162621
[TBL] [Abstract][Full Text] [Related]
14. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
15. [The contribution of social medicine to vaccination in Austria].
Kunze M
Wien Med Wochenschr; 1998; 148(8-9):191-7. PubMed ID: 9677675
[TBL] [Abstract][Full Text] [Related]
16. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
17. Variation and consternation: access to unfunded cancer drugs in Canada.
Berry SR; Evans WK; Strevel EL; Bell CM
J Oncol Pract; 2012 Jan; 8(1):35-9. PubMed ID: 22548009
[TBL] [Abstract][Full Text] [Related]
18. A patchwork of funding sources for Norplant users in the U.S.
Antarsh L
AVSC News; 1992 Sep; 30(3):1-2. PubMed ID: 12285829
[TBL] [Abstract][Full Text] [Related]
19. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
Shen AK; Rodewald LE; Birkhead GS
Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
[TBL] [Abstract][Full Text] [Related]
20. Financing immunization of adults in the United States.
Orenstein WA; Mootrey GT; Pazol K; Hinman AR
Clin Pharmacol Ther; 2007 Dec; 82(6):764-8. PubMed ID: 17971821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
